2.15
2.15 (-0.15%)
As of Mar 06, 2024
Corvus Pharmaceuticals, Inc. [CRVS]
Source:
Company Overview
Corvus Pharmaceuticals, Inc is a clinical stage biopharmaceutical company. Our strategy is to focus our efforts on the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. We have built a pipeline of five programs, three of which are in clinical development.
Country | United States |
Headquarters | burlingame, california |
Phone Number | (650) 900-4520 |
Industry | manufacturing |
CEO | Richard A. Miller |
Website | www.clinicaltrials.gov |